Acute lymphoid leukemia: genes and variants
Explore variant evidence for Acute lymphoid leukemia across 19 analyzed proteins (PAX5, FLT3, IKZF1, BCR, ETV6 and 14 more). Linked ClinVar records include 5 pathogenic or likely pathogenic variants, 31 variants of uncertain significance and 10 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Acute lymphoid leukemia
PAX5: Paired box protein Pax-5
It establishes and maintains B-cell identity by activating B-lineage genes and repressing alternative developmental programs. Somatic loss, mutation, or rearrangement is common in B-cell acute lymphoblastic leukemia, while germline variants can confer leukemia susceptibility and immunodeficiency.
3 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in PAX5 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
FLT3: Receptor-type tyrosine-protein kinase FLT3
Its signaling supports survival and expansion of early hematopoietic progenitors. Internal tandem duplications and kinase-domain mutations produce constitutive activity in acute myeloid leukemia and are important prognostic markers and therapeutic targets.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FLT3 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
IKZF1: DNA-binding protein Ikaros
It establishes transcriptional programs required for lymphoid development, especially B-cell differentiation. Somatic deletion or mutation is common in high-risk B-cell acute lymphoblastic leukemia, while germline variants can cause immunodeficiency and leukemia predisposition.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IKZF1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
BCR: Breakpoint cluster region protein
It has serine/threonine kinase and GTPase-regulatory functions involved in cytoskeletal and signaling control. Chromosomal fusion with ABL1 creates the constitutively active BCR::ABL1 kinase that drives chronic myeloid leukemia and subsets of acute leukemia.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in BCR have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
ETV6: Transcription factor ETV6
It normally restrains hematopoietic transcriptional programs and is important for blood-cell development and vascular biology. Germline loss-of-function variants can cause thrombocytopenia with leukemia predisposition, while numerous ETV6 fusion genes drive leukemias and other cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ETV6 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
ABL1: Tyrosine-protein kinase ABL1
It coordinates cytoskeletal remodeling, adhesion, DNA-damage responses, and growth signaling through tightly regulated tyrosine phosphorylation. Fusion with BCR removes normal control and creates the constitutively active kinase that drives chronic myeloid leukemia and subsets of acute lymphoblastic leukemia.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABL1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
CD19: B-lymphocyte antigen CD19
It amplifies B-cell receptor signaling and helps set the threshold for B-cell activation throughout much of B-cell development. Loss-of-function variants can cause antibody deficiency, while its lineage-restricted surface expression makes it a major target for monoclonal antibodies and CAR-T therapy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CD19 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
CD3D: T-cell surface glycoprotein CD3 delta chain
Within the T-cell receptor complex, it transmits antigen-recognition signals into developing and mature T cells. Biallelic loss-of-function variants can cause severe combined immunodeficiency or related T-cell immunodeficiency.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CD3D have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
CD3E: T-cell surface glycoprotein CD3 epsilon chain
It helps assemble the T-cell receptor complex and transduces antigen-recognition signals through its cytoplasmic signaling motifs. Biallelic pathogenic variants can impair T-cell development and cause severe combined immunodeficiency.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CD3E have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
CUX1: Homeobox protein cut-like 1
It regulates transcription and chromatin-associated processes involved in cell differentiation, proliferation, and neuronal development. Haploinsufficiency can cause neurodevelopmental impairment, while somatic loss is common in myeloid malignancies and often marks adverse-risk disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CUX1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
IMPDH1: Inosine-5'-monophosphate dehydrogenase 1
An enzyme that catalyzes a rate-limiting step in guanine-nucleotide synthesis. Specialized retinal isoforms help regulate nucleotide production in photoreceptors, and pathogenic variants can cause inherited retinal dystrophy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IMPDH1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
KIT: Mast/stem cell growth factor receptor Kit
Stem-cell-factor signaling through this pathway supports hematopoietic progenitors, mast cells, melanocytes, and germ cells. Activating variants drive gastrointestinal stromal tumors, systemic mastocytosis, and other malignancies, whereas loss-of-function variants can cause piebaldism.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KIT have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
LCK: Tyrosine-protein kinase Lck
It phosphorylates the earliest signaling components downstream of the T-cell receptor and CD4 or CD8 coreceptors, making it essential for T-cell development and activation. Severe loss-of-function can cause combined immunodeficiency, while aberrant activity contributes to lymphoid malignancy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in LCK have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
MS4A1: B-lymphocyte antigen CD20
Its expression spans much of B-cell development and contributes to calcium signaling and B-cell activation. Its stable surface expression makes it a major therapeutic target for B-cell depletion in lymphoma, leukemia, and autoimmune disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in MS4A1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
PDGFRB: Platelet-derived growth factor receptor beta
Its signaling supports pericytes, vascular smooth-muscle cells, and other mesenchymal lineages during growth and tissue repair. Oncogenic fusions drive myeloid neoplasms, while germline activating or loss-of-function variants can cause developmental and vascular disorders.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PDGFRB have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
POLD1: DNA polymerase delta catalytic subunit
It performs much of lagging-strand DNA synthesis and proofreads newly replicated DNA through its exonuclease activity. Germline proofreading-domain variants cause polymerase-proofreading-associated polyposis and cancer predisposition, while other variants can produce developmental progeroid syndromes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in POLD1 have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
POLE: DNA polymerase epsilon catalytic subunit A
It performs leading-strand DNA synthesis and proofreads newly incorporated bases during replication. Germline exonuclease-domain variants cause polymerase-proofreading-associated polyposis, while somatic proofreading defects create ultramutated tumors with distinctive mutation signatures.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in POLE have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
SRC: Proto-oncogene tyrosine-protein kinase Src
It integrates signals from growth-factor receptors, integrins, and other surface proteins to regulate proliferation, adhesion, migration, and survival. Persistent SRC-family signaling promotes invasion and therapy resistance in many cancers and remains an important therapeutic target.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SRC have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
NBN: Nibrin
It recruits and organizes the MRE11-RAD50 complex at DNA double-strand breaks and helps activate ATM-dependent DNA-damage responses. Biallelic loss-of-function variants cause Nijmegen breakage syndrome with microcephaly, immunodeficiency, chromosome instability, and high cancer risk.
0 ClinVar pathogenic / likely pathogenic and 36 uncertain variants in NBN have source records linked to Acute lymphoid leukemia. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CDKN2A.
ClinVar pathogenic and likely pathogenic variants linked to Acute lymphoid leukemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| PAX5 V26G | 26 | Paired | Pathogenic / likely pathogenic (★) |
| PAX5 P130T | 130 | Paired | Pathogenic / likely pathogenic (★) |
| PAX5 S134C | 134 | Paired | Pathogenic / likely pathogenic (★) |
| FLT3 D835Y | 835 | Protein kinase | Pathogenic / likely pathogenic |
| FLT3 D835V | 835 | Protein kinase | Pathogenic / likely pathogenic |
Same protein, different disease
- Acute myeloid leukemia also has ClinVar records linked to FLT3 variants; they fall mostly in different places as the Acute lymphoid leukemia variants (7 pathogenic / likely pathogenic).
Diseases related to Acute lymphoid leukemia
- Acute myeloid leukemia, also linked to ETV6, FLT3, KIT, PDGFRB and 2 more
- Chronic myeloid leukemia, also linked to ABL1, BCR, KIT, LCK and 2 more
- Gastrointestinal stromal tumor, also linked to ABL1, BCR, FLT3, KIT and 1 more
- Colorectal cancer, also linked to ABL1, KIT, PDGFRB, POLD1 and 1 more
- Ovarian cancer, also linked to KIT, NBN, POLD1 and POLE
- Renal cell carcinoma, also linked to FLT3, KIT, LCK and PDGFRB
- Non-small cell lung carcinoma, also linked to PDGFRB, POLD1 and POLE
- Multiple myeloma, also linked to CD3D, CD3E and FLT3
- Hepatocellular carcinoma, also linked to FLT3, KIT and PDGFRB
- Familial colorectal cancer, also linked to POLD1 and POLE
- Retinitis pigmentosa, also linked to IMPDH1
- Hypertrophic cardiomyopathy, also linked to SRC
Frequently asked questions
Which genes have records linked to Acute lymphoid leukemia?
This view contains 19 analyzed proteins: PAX5, FLT3, IKZF1, BCR, ETV6 and 14 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 5 pathogenic or likely pathogenic variants, 31 variants of uncertain significance and 10 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 69 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center